Amgen
AMGN
2,030 hedge funds and large institutions have $91.9B invested in Amgen in 2020 Q1 according to their latest regulatory filings, with 105 funds opening new positions, 789 increasing their positions, 870 reducing their positions, and 155 closing their positions.
6% more funds holding in top 10
Funds holding in top 10: 112 → 119 (+7)
0.05% less ownership
Funds ownership: 76.98% → 76.93% (-0.05%)
3% less call options, than puts
Call options by funds: $1.1B | Put options by funds: $1.14B
9% less repeat investments, than reductions
Existing positions increased: 789 | Existing positions reduced: 870
4% less funds holding
Funds holding: 2,108 → 2,030 (-78)
16% less capital invested
Capital invested by funds: $110B → $91.9B (-$18B)
32% less first-time investments, than exits
New positions opened: 105 | Existing positions closed: 155
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ClearBridge Investments
New York
|
+$541M |
| 2 |
JP Morgan Chase
New York
|
+$257M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$256M |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$204M |
| 5 |
AIG
American International Group
New York
|
+$190M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.49B |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$486M |
| 3 |
Goldman Sachs
New York
|
-$298M |
| 4 |
JFA
Johanson Financial Advisors
Campbell,
California
|
-$265M |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$139M |
AMGN Hedge Fund Activity: Q1 2020 in Review
2,030 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q1 2020, worth a combined $91.9B — down 16% from $110B a quarter earlier.
Sellers outnumbered buyers: 155 funds closed out of AMGN and 105 opened new positions — a net loss of 50 holders — while 870 trimmed existing stakes and 789 added.
The largest buyer was ClearBridge Investments, adding an estimated $541M. The largest seller was Fidelity Investments, cutting an estimated $1.49B.
- 2,030 institutional investors held Amgen (AMGN) as of Q1 2020, down from 2,108 in Q4 2019.
- Funds reported $91.9B of Amgen stock for Q1 2020, down 16% quarter-over-quarter.
- 105 funds opened new Amgen positions in Q1 2020 and 155 closed out, a net change of -50 holders.
- The largest Amgen buyer in Q1 2020 was ClearBridge Investments, an estimated $541M added.
- The largest Amgen seller in Q1 2020 was Fidelity Investments, an estimated $1.49B sold.
Based on aggregated 13F filings for Q1 2020.